+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Stem Cell Therapy Market by Therapy Type (Allogeneic Therapy, Autologous Therapy), Cell Source (Adult Stem Cells, Embryonic Stem Cells, Induced Pluripotent Stem Cells), Technology, Mode of Administration, Application, Therapeutic Areas, End User - Global Forecast 2025-2030- Product Image
Stem Cell Therapy Market by Therapy Type (Allogeneic Therapy, Autologous Therapy), Cell Source (Adult Stem Cells, Embryonic Stem Cells, Induced Pluripotent Stem Cells), Technology, Mode of Administration, Application, Therapeutic Areas, End User - Global Forecast 2025-2030- Product Image
Sale

Stem Cell Therapy Market by Therapy Type (Allogeneic Therapy, Autologous Therapy), Cell Source (Adult Stem Cells, Embryonic Stem Cells, Induced Pluripotent Stem Cells), Technology, Mode of Administration, Application, Therapeutic Areas, End User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 183 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 5336434
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The global stem cell therapy market is progressing rapidly as advancements in biotechnology and new clinical applications are transforming regenerative medicine. Senior decision-makers will find actionable intelligence in this report, streamlined for assessing opportunity, risk, and investment priorities across the sector.

Market Snapshot: Stem Cell Therapy Market Growth & Outlook

The Stem Cell Therapy Market grew from USD 4.45 billion in 2024 to USD 5.08 billion in 2025. It is expected to continue growing at a CAGR of 14.33%, reaching USD 9.95 billion by 2030. This expansion is fueled by growing integration of stem cell therapies into clinical practice, supported by robust R&D, cross-sector collaborations, and a maturing global regulatory landscape. Diverse therapeutic areas—including neurology, cardiology, and immuno-oncology—are being shaped by ongoing innovation, while both public and private funding are reinforcing commercial momentum.

Scope & Segmentation of the Stem Cell Therapy Market

This report provides a detailed examination of the market’s core segments, regional dynamics, and cutting-edge technologies:

  • Therapy Types: Coverage includes both allogeneic therapies using donor stem cells and autologous approaches leveraging patient-derived material for individualized treatments.
  • Cell Sources: Analysis spans adult stem cells—including hematopoietic, mesenchymal, and neural—embryonic stem cells, induced pluripotent stem cells, and perinatal sources such as amniotic fluid and umbilical cord.
  • Technologies: The landscape encompasses biomaterial-based and scaffold-based therapies, ex vivo expansion platforms, and gene-edited technologies supporting functional enhancement and scalability.
  • Modes of Administration: Examined routes include intra-articular, intramuscular, and intravenous delivery, each tailored to specific therapeutic contexts.
  • Application Areas: The report analyzes platforms supporting drug discovery and development, regenerative medicine, and tissue engineering for complex tissue reconstruction.
  • Therapeutic Areas: Key focus areas are cardiovascular disease, hematology, musculoskeletal and neurological disorders, and oncology.
  • End Users: Stakeholders include academic and research institutes driving innovation, biopharmaceutical companies commercializing therapies, hospitals and clinics administering treatments, and dedicated stem cell banks.
  • Regional Markets: Evaluation covers North America, Europe, Middle East, Africa, and Asia-Pacific, with deep dives into primary countries and growth hubs in each region.

Key Takeaways for Decision-Makers

  • Emerging stem cell modalities are swiftly transitioning from experimental to clinical settings, driving personalized and precision-guided treatments.
  • The convergence of gene editing, automated manufacturing, and AI-powered quality control is enabling higher scalability and consistency in therapeutic development.
  • Strategic alliances—across industry, academia, and contract organizations—are proving vital for de-risking pipelines and accelerating translational research.
  • Diverse regional regulatory frameworks and dynamic market entry pathways heighten the need for tailored commercialization strategies worldwide.
  • Real-world evidence and integration of digital health data are essential for payers’ value assessments and for sustained therapy adoption.
  • Building resilient, diversified supply chains is an imperative as input-dependent manufacturers and researchers respond to ongoing geopolitical and policy shifts.

Impact of United States 2025 Tariff Policies

The introduction of higher tariffs in 2025 on biotechnological imports to the United States significantly affected the stem cell therapy value chain. Components such as cell culture reagents and single-use consumables experienced notable cost increases. Companies are now mitigating risk through nearshoring, local partnerships, and supplier diversification, while research and development teams are carefully reallocating resources to prioritize platform technologies that streamline production and manage costs under the new tariff environment.

Methodology & Data Sources

This executive summary leverages a primary research protocol that included over 50 hours of qualitative interviews with industry leaders, regulators, and subject matter experts. Insights were triangulated with secondary data from scientific literature, regulatory filings, and industry intelligence platforms to validate findings and ensure comprehensive coverage.

Why This Report Matters to Senior Decision-Makers

  • Uncovers actionable insights into market positioning, opportunity mapping, and risk management tailored to investment and strategic planning needs.
  • Offers a cohesive, segmented view of technologies, therapeutic pathways, and shifting regulatory frameworks that enable agile decision-making.
  • Provides granular analysis to inform R&D prioritization, competitive benchmarking, and localization strategies for market entry.

Conclusion

This report delivers a clear, evidence-based roadmap for navigating the growing stem cell therapy market. Senior leaders can leverage these insights for strategic growth, risk mitigation, and accelerated commercialization in a dynamic, high-potential sector.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Rising adoption of exosome-based therapeutics derived from stem cells as cell-free regenerative medicine alternatives
5.2. Advancements in autologous adipose-derived stem cell therapies for osteoarthritis pain management
5.3. Regulatory approval pathways for gene-edited stem cell therapies targeting hematologic disorders
5.4. Integration of 3D bioprinting techniques with induced pluripotent stem cells for organ regeneration research
5.5. Commercialization challenges and reimbursement strategies for mesenchymal stem cell products in sports medicine
5.6. Emergence of off-the-shelf allogeneic neural stem cell treatments for spinal cord injury recovery
5.7. Application of artificial intelligence in optimizing stem cell manufacturing and quality control workflows
5.8. Clinical trial expansions targeting neurological disorders with induced pluripotent stem cell therapies
5.9. Innovations in biomaterial scaffolds improving cell engraftment and tissue regeneration outcomes in stem cell therapy
5.10. Emerging point-of-care autologous cell therapy devices enhancing treatment accessibility and scalability
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Stem Cell Therapy Market, by Therapy Type
8.1. Introduction
8.2. Allogeneic Therapy
8.3. Autologous Therapy
9. Stem Cell Therapy Market, by Cell Source
9.1. Introduction
9.2. Adult Stem Cells
9.2.1. Hematopoietic Stem Cells
9.2.2. Mesenchymal Stem Cells
9.2.3. Neural Stem Cells
9.3. Embryonic Stem Cells
9.4. Induced Pluripotent Stem Cells
9.5. Perinatal Stem Cells
9.5.1. Amniotic Fluid Stem Cells
9.5.2. Umbilical Cord Stem Cells
10. Stem Cell Therapy Market, by Technology
10.1. Introduction
10.2. Biomaterial Based Therapy
10.3. Ex Vivo Expansion
10.4. Gene Edited Technologies
10.5. Scaffold Based Therapy
11. Stem Cell Therapy Market, by Mode of Administration
11.1. Introduction
11.2. Intra-articular
11.3. Intramuscular
11.4. Intravenous
12. Stem Cell Therapy Market, by Application
12.1. Introduction
12.2. Drug Discovery & Development
12.3. Regenerative Medicine
12.4. Tissue Engineering
13. Stem Cell Therapy Market, by Therapeutic Areas
13.1. Introduction
13.2. Cardiovascular Diseases
13.3. Hematology
13.4. Musculoskeletal Disorders
13.5. Neurological Disorders
13.6. Oncology
14. Stem Cell Therapy Market, by End User
14.1. Introduction
14.2. Academic & Research Institutes
14.3. Biopharmaceutical Companies
14.4. Hospitals & Clinics
14.5. Stem Cell Banks
15. Americas Stem Cell Therapy Market
15.1. Introduction
15.2. United States
15.3. Canada
15.4. Mexico
15.5. Brazil
15.6. Argentina
16. Europe, Middle East & Africa Stem Cell Therapy Market
16.1. Introduction
16.2. United Kingdom
16.3. Germany
16.4. France
16.5. Russia
16.6. Italy
16.7. Spain
16.8. United Arab Emirates
16.9. Saudi Arabia
16.10. South Africa
16.11. Denmark
16.12. Netherlands
16.13. Qatar
16.14. Finland
16.15. Sweden
16.16. Nigeria
16.17. Egypt
16.18. Turkey
16.19. Israel
16.20. Norway
16.21. Poland
16.22. Switzerland
17. Asia-Pacific Stem Cell Therapy Market
17.1. Introduction
17.2. China
17.3. India
17.4. Japan
17.5. Australia
17.6. South Korea
17.7. Indonesia
17.8. Thailand
17.9. Philippines
17.10. Malaysia
17.11. Singapore
17.12. Vietnam
17.13. Taiwan
18. Competitive Landscape
18.1. Market Share Analysis, 2024
18.2. FPNV Positioning Matrix, 2024
18.3. Competitive Analysis
18.3.1. BrainStorm Cell Therapeutics Inc.
18.3.2. Merck KGaA
18.3.3. Anterogen Co., Ltd.
18.3.4. Astellas Pharma Inc.
18.3.5. Beike Biotechnology Co., Ltd.
18.3.6. Bristol-Myers Squibb Company
18.3.7. CellProthera SAS
18.3.8. Fate Therapeutics, Inc.
18.3.9. Gamida Cell Ltd.
18.3.10. Garuda Therapeutics
18.3.11. Holostem Terapie Avanzate S.r.l.
18.3.12. Jasper Therapeutics, Inc.
18.3.13. JCR Pharmaceuticals Co., Ltd.
18.3.14. Juvena Therapeutics Inc.
18.3.15. Kangstem Biotech Co., Ltd.
18.3.16. Kite Pharma, Inc. by Gilead Sciences, Inc.
18.3.17. Lonza Group AG
18.3.18. Medeze Group
18.3.19. Mesoblast Ltd.
18.3.20. Novo Nordisk A/S
18.3.21. Plasticell
18.3.22. ReNeuron Group PLC
18.3.23. SQZ Biotechnologies Company by Stemcell Technologies
18.3.24. Takara Bio Inc.
18.3.25. Thermo Fisher Scientific Inc.
18.3.26. U.S. Stem Cell Inc
18.3.27. Umoja Biopharma
18.3.28. Vericel Corporation
19. ResearchAI
20. ResearchStatistics
21. ResearchContacts
22. ResearchArticles
23. Appendix
List of Figures
FIGURE 1. STEM CELL THERAPY MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL STEM CELL THERAPY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL STEM CELL THERAPY MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL STEM CELL THERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL STEM CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL STEM CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL STEM CELL THERAPY MARKET SIZE, BY CELL SOURCE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL STEM CELL THERAPY MARKET SIZE, BY CELL SOURCE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL STEM CELL THERAPY MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 10. GLOBAL STEM CELL THERAPY MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL STEM CELL THERAPY MARKET SIZE, BY MODE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL STEM CELL THERAPY MARKET SIZE, BY MODE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL STEM CELL THERAPY MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 14. GLOBAL STEM CELL THERAPY MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL STEM CELL THERAPY MARKET SIZE, BY THERAPEUTIC AREAS, 2024 VS 2030 (%)
FIGURE 16. GLOBAL STEM CELL THERAPY MARKET SIZE, BY THERAPEUTIC AREAS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL STEM CELL THERAPY MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 18. GLOBAL STEM CELL THERAPY MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. AMERICAS STEM CELL THERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. AMERICAS STEM CELL THERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. UNITED STATES STEM CELL THERAPY MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 22. UNITED STATES STEM CELL THERAPY MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA STEM CELL THERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA STEM CELL THERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. ASIA-PACIFIC STEM CELL THERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. ASIA-PACIFIC STEM CELL THERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. STEM CELL THERAPY MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 28. STEM CELL THERAPY MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 29. STEM CELL THERAPY MARKET: RESEARCHAI
FIGURE 30. STEM CELL THERAPY MARKET: RESEARCHSTATISTICS
FIGURE 31. STEM CELL THERAPY MARKET: RESEARCHCONTACTS
FIGURE 32. STEM CELL THERAPY MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. STEM CELL THERAPY MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL STEM CELL THERAPY MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL STEM CELL THERAPY MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL STEM CELL THERAPY MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL STEM CELL THERAPY MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL STEM CELL THERAPY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL STEM CELL THERAPY MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL STEM CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL STEM CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL STEM CELL THERAPY MARKET SIZE, BY ALLOGENEIC THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL STEM CELL THERAPY MARKET SIZE, BY ALLOGENEIC THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL STEM CELL THERAPY MARKET SIZE, BY AUTOLOGOUS THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL STEM CELL THERAPY MARKET SIZE, BY AUTOLOGOUS THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL STEM CELL THERAPY MARKET SIZE, BY CELL SOURCE, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL STEM CELL THERAPY MARKET SIZE, BY CELL SOURCE, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL STEM CELL THERAPY MARKET SIZE, BY ADULT STEM CELLS, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL STEM CELL THERAPY MARKET SIZE, BY ADULT STEM CELLS, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL STEM CELL THERAPY MARKET SIZE, BY HEMATOPOIETIC STEM CELLS, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL STEM CELL THERAPY MARKET SIZE, BY HEMATOPOIETIC STEM CELLS, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL STEM CELL THERAPY MARKET SIZE, BY MESENCHYMAL STEM CELLS, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL STEM CELL THERAPY MARKET SIZE, BY MESENCHYMAL STEM CELLS, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL STEM CELL THERAPY MARKET SIZE, BY NEURAL STEM CELLS, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL STEM CELL THERAPY MARKET SIZE, BY NEURAL STEM CELLS, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL STEM CELL THERAPY MARKET SIZE, BY ADULT STEM CELLS, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL STEM CELL THERAPY MARKET SIZE, BY ADULT STEM CELLS, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL STEM CELL THERAPY MARKET SIZE, BY EMBRYONIC STEM CELLS, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL STEM CELL THERAPY MARKET SIZE, BY EMBRYONIC STEM CELLS, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL STEM CELL THERAPY MARKET SIZE, BY INDUCED PLURIPOTENT STEM CELLS, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL STEM CELL THERAPY MARKET SIZE, BY INDUCED PLURIPOTENT STEM CELLS, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL STEM CELL THERAPY MARKET SIZE, BY PERINATAL STEM CELLS, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL STEM CELL THERAPY MARKET SIZE, BY PERINATAL STEM CELLS, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL STEM CELL THERAPY MARKET SIZE, BY AMNIOTIC FLUID STEM CELLS, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL STEM CELL THERAPY MARKET SIZE, BY AMNIOTIC FLUID STEM CELLS, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL STEM CELL THERAPY MARKET SIZE, BY UMBILICAL CORD STEM CELLS, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL STEM CELL THERAPY MARKET SIZE, BY UMBILICAL CORD STEM CELLS, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL STEM CELL THERAPY MARKET SIZE, BY PERINATAL STEM CELLS, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL STEM CELL THERAPY MARKET SIZE, BY PERINATAL STEM CELLS, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL STEM CELL THERAPY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL STEM CELL THERAPY MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL STEM CELL THERAPY MARKET SIZE, BY BIOMATERIAL BASED THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL STEM CELL THERAPY MARKET SIZE, BY BIOMATERIAL BASED THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL STEM CELL THERAPY MARKET SIZE, BY EX VIVO EXPANSION, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL STEM CELL THERAPY MARKET SIZE, BY EX VIVO EXPANSION, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL STEM CELL THERAPY MARKET SIZE, BY GENE EDITED TECHNOLOGIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL STEM CELL THERAPY MARKET SIZE, BY GENE EDITED TECHNOLOGIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL STEM CELL THERAPY MARKET SIZE, BY SCAFFOLD BASED THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL STEM CELL THERAPY MARKET SIZE, BY SCAFFOLD BASED THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL STEM CELL THERAPY MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL STEM CELL THERAPY MARKET SIZE, BY MODE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL STEM CELL THERAPY MARKET SIZE, BY INTRA-ARTICULAR, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL STEM CELL THERAPY MARKET SIZE, BY INTRA-ARTICULAR, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL STEM CELL THERAPY MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL STEM CELL THERAPY MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL STEM CELL THERAPY MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL STEM CELL THERAPY MARKET SIZE, BY INTRAVENOUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL STEM CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL STEM CELL THERAPY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL STEM CELL THERAPY MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL STEM CELL THERAPY MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL STEM CELL THERAPY MARKET SIZE, BY REGENERATIVE MEDICINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL STEM CELL THERAPY MARKET SIZE, BY REGENERATIVE MEDICINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL STEM CELL THERAPY MARKET SIZE, BY TISSUE ENGINEERING, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL STEM CELL THERAPY MARKET SIZE, BY TISSUE ENGINEERING, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL STEM CELL THERAPY MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL STEM CELL THERAPY MARKET SIZE, BY THERAPEUTIC AREAS, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL STEM CELL THERAPY MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL STEM CELL THERAPY MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL STEM CELL THERAPY MARKET SIZE, BY HEMATOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL STEM CELL THERAPY MARKET SIZE, BY HEMATOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL STEM CELL THERAPY MARKET SIZE, BY MUSCULOSKELETAL DISORDERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL STEM CELL THERAPY MARKET SIZE, BY MUSCULOSKELETAL DISORDERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL STEM CELL THERAPY MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL STEM CELL THERAPY MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL STEM CELL THERAPY MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL STEM CELL THERAPY MARKET SIZE, BY ONCOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL STEM CELL THERAPY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL STEM CELL THERAPY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL STEM CELL THERAPY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL STEM CELL THERAPY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL STEM CELL THERAPY MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL STEM CELL THERAPY MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL STEM CELL THERAPY MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL STEM CELL THERAPY MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL STEM CELL THERAPY MARKET SIZE, BY STEM CELL BANKS, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL STEM CELL THERAPY MARKET SIZE, BY STEM CELL BANKS, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. AMERICAS STEM CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 88. AMERICAS STEM CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 89. AMERICAS STEM CELL THERAPY MARKET SIZE, BY CELL SOURCE, 2018-2024 (USD MILLION)
TABLE 90. AMERICAS STEM CELL THERAPY MARKET SIZE, BY CELL SOURCE, 2025-2030 (USD MILLION)
TABLE 91. AMERICAS STEM CELL THERAPY MARKET SIZE, BY ADULT STEM CELLS, 2018-2024 (USD MILLION)
TABLE 92. AMERICAS STEM CELL THERAPY MARKET SIZE, BY ADULT STEM CELLS, 2025-2030 (USD MILLION)
TABLE 93. AMERICAS STEM CELL THERAPY MARKET SIZE, BY PERINATAL STEM CELLS, 2018-2024 (USD MILLION)
TABLE 94. AMERICAS STEM CELL THERAPY MARKET SIZE, BY PERINATAL STEM CELLS, 2025-2030 (USD MILLION)
TABLE 95. AMERICAS STEM CELL THERAPY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 96. AMERICAS STEM CELL THERAPY MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 97. AMERICAS STEM CELL THERAPY MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 98. AMERICAS STEM CELL THERAPY MARKET SIZE, BY MODE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 99. AMERICAS STEM CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 100. AMERICAS STEM CELL THERAPY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 101. AMERICAS STEM CELL THERAPY MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2024 (USD MILLION)
TABLE 102. AMERICAS STEM CELL THERAPY MARKET SIZE, BY THERAPEUTIC AREAS, 2025-2030 (USD MILLION)
TABLE 103. AMERICAS STEM CELL THERAPY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 104. AMERICAS STEM CELL THERAPY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 105. AMERICAS STEM CELL THERAPY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 106. AMERICAS STEM CELL THERAPY MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 107. UNITED STATES STEM CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 108. UNITED STATES STEM CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 109. UNITED STATES STEM CELL THERAPY MARKET SIZE, BY CELL SOURCE, 2018-2024 (USD MILLION)
TABLE 110. UNITED STATES STEM CELL THERAPY MARKET SIZE, BY CELL SOURCE, 2025-2030 (USD MILLION)
TABLE 111. UNITED STATES STEM CELL THERAPY MARKET SIZE, BY ADULT STEM CELLS, 2018-2024 (USD MILLION)
TABLE 112. UNITED STATES STEM CELL THERAPY MARKET SIZE, BY ADULT STEM CELLS, 2025-2030 (USD MILLION)
TABLE 113. UNITED STATES STEM CELL THERAPY MARKET SIZE, BY PERINATAL STEM CELLS, 2018-2024 (USD MILLION)
TABLE 114. UNITED STATES STEM CELL THERAPY MARKET SIZE, BY PERINATAL STEM CELLS, 2025-2030 (USD MILLION)
TABLE 115. UNITED STATES STEM CELL THERAPY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 116. UNITED STATES STEM CELL THERAPY MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 117. UNITED STATES STEM CELL THERAPY MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 118. UNITED STATES STEM CELL THERAPY MARKET SIZE, BY MODE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 119. UNITED STATES STEM CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 120. UNITED STATES STEM CELL THERAPY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 121. UNITED STATES STEM CELL THERAPY MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2024 (USD MILLION)
TABLE 122. UNITED STATES STEM CELL THERAPY MARKET SIZE, BY THERAPEUTIC AREAS, 2025-2030 (USD MILLION)
TABLE 123. UNITED STATES STEM CELL THERAPY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 124. UNITED STATES STEM CELL THERAPY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 125. UNITED STATES STEM CELL THERAPY MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 126. UNITED STATES STEM CELL THERAPY MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 127. CANADA STEM CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 128. CANADA STEM CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 129. CANADA STEM CELL THERAPY MARKET SIZE, BY CELL SOURCE, 2018-2024 (USD MILLION)
TABLE 130. CANADA STEM CELL THERAPY MARKET SIZE, BY CELL SOURCE, 2025-2030 (USD MILLION)
TABLE 131. CANADA STEM CELL THERAPY MARKET SIZE, BY ADULT STEM CELLS, 2018-2024 (USD MILLION)
TABLE 132. CANADA STEM CELL THERAPY MARKET SIZE, BY ADULT STEM CELLS, 2025-2030 (USD MILLION)
TABLE 133. CANADA STEM CELL THERAPY MARKET SIZE, BY PERINATAL STEM CELLS, 2018-2024 (USD MILLION)
TABLE 134. CANADA STEM CELL THERAPY MARKET SIZE, BY PERINATAL STEM CELLS, 2025-2030 (USD MILLION)
TABLE 135. CANADA STEM CELL THERAPY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 136. CANADA STEM CELL THERAPY MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 137. CANADA STEM CELL THERAPY MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 138. CANADA STEM CELL THERAPY MARKET SIZE, BY MODE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 139. CANADA STEM CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 140. CANADA STEM CELL THERAPY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 141. CANADA STEM CELL THERAPY MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2024 (USD MILLION)
TABLE 142. CANADA STEM CELL THERAPY MARKET SIZE, BY THERAPEUTIC AREAS, 2025-2030 (USD MILLION)
TABLE 143. CANADA STEM CELL THERAPY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 144. CANADA STEM CELL THERAPY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 145. MEXICO STEM CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 146. MEXICO STEM CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 147. MEXICO STEM CELL THERAPY MARKET SIZE, BY CELL SOURCE, 2018-2024 (USD MILLION)
TABLE 148. MEXICO STEM CELL THERAPY MARKET SIZE, BY CELL SOURCE, 2025-2030 (USD MILLION)
TABLE 149. MEXICO STEM CELL THERAPY MARKET SIZE, BY ADULT STEM CELLS, 2018-2024 (USD MILLION)
TABLE 150. MEXICO STEM CELL THERAPY MARKET SIZE, BY ADULT STEM CELLS, 2025-2030 (USD MILLION)
TABLE 151. MEXICO STEM CELL THERAPY MARKET SIZE, BY PERINATAL STEM CELLS, 2018-2024 (USD MILLION)
TABLE 152. MEXICO STEM CELL THERAPY MARKET SIZE, BY PERINATAL STEM CELLS, 2025-2030 (USD MILLION)
TABLE 153. MEXICO STEM CELL THERAPY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 154. MEXICO STEM CELL THERAPY MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 155. MEXICO STEM CELL THERAPY MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 156. MEXICO STEM CELL THERAPY MARKET SIZE, BY MODE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 157. MEXICO STEM CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 158. MEXICO STEM CELL THERAPY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 159. MEXICO STEM CELL THERAPY MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2024 (USD MILLION)
TABLE 160. MEXICO STEM CELL THERAPY MARKET SIZE, BY THERAPEUTIC AREAS, 2025-2030 (USD MILLION)
TABLE 161. MEXICO STEM CELL THERAPY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 162. MEXICO STEM CELL THERAPY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 163. BRAZIL STEM CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 164. BRAZIL STEM CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 165. BRAZIL STEM CELL THERAPY MARKET SIZE, BY CELL SOURCE, 2018-2024 (USD MILLION)
TABLE 166. BRAZIL STEM CELL THERAPY MARKET SIZE, BY CELL SOURCE, 2025-2030 (USD MILLION)
TABLE 167. BRAZIL STEM CELL THERAPY MARKET SIZE, BY ADULT STEM CELLS, 2018-2024 (USD MILLION)
TABLE 168. BRAZIL STEM CELL THERAPY MARKET SIZE, BY ADULT STEM CELLS, 2025-2030 (USD MILLION)
TABLE 169. BRAZIL STEM CELL THERAPY MARKET SIZE, BY PERINATAL STEM CELLS, 2018-2024 (USD MILLION)
TABLE 170. BRAZIL STEM CELL THERAPY MARKET SIZE, BY PERINATAL STEM CELLS, 2025-2030 (USD MILLION)
TABLE 171. BRAZIL STEM CELL THERAPY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 172. BRAZIL STEM CELL THERAPY MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 173. BRAZIL STEM CELL THERAPY MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 174. BRAZIL STEM CELL THERAPY MARKET SIZE, BY MODE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 175. BRAZIL STEM CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 176. BRAZIL STEM CELL THERAPY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 177. BRAZIL STEM CELL THERAPY MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2024 (USD MILLION)
TABLE 178. BRAZIL STEM CELL THERAPY MARKET SIZE, BY THERAPEUTIC AREAS, 2025-2030 (USD MILLION)
TABLE 179. BRAZIL STEM CELL THERAPY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 180. BRAZIL STEM CELL THERAPY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 181. ARGENTINA STEM CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 182. ARGENTINA STEM CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 183. ARGENTINA STEM CELL THERAPY MARKET SIZE, BY CELL SOURCE, 2018-2024 (USD MILLION)
TABLE 184. ARGENTINA STEM CELL THERAPY MARKET SIZE, BY CELL SOURCE, 2025-2030 (USD MILLION)
TABLE 185. ARGENTINA STEM CELL THERAPY MARKET SIZE, BY ADULT STEM CELLS, 2018-2024 (USD MILLION)
TABLE 186. ARGENTINA STEM CELL THERAPY MARKET SIZE, BY ADULT STEM CELLS, 2025-2030 (USD MILLION)
TABLE 187. ARGENTINA STEM CELL THERAPY MARKET SIZE, BY PERINATAL STEM CELLS, 2018-2024 (USD MILLION)
TABLE 188. ARGENTINA STEM CELL THERAPY MARKET SIZE, BY PERINATAL STEM CELLS, 2025-2030 (USD MILLION)
TABLE 189. ARGENTINA STEM CELL THERAPY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 190. ARGENTINA STEM CELL THERAPY MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 191. ARGENTINA STEM CELL THERAPY MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 192. ARGENTINA STEM CELL THERAPY MARKET SIZE, BY MODE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 193. ARGENTINA STEM CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 194. ARGENTINA STEM CELL THERAPY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 195. ARGENTINA STEM CELL THERAPY MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2024 (USD MILLION)
TABLE 196. ARGENTINA STEM CELL THERAPY MARKET SIZE, BY THERAPEUTIC AREAS, 2025-2030 (USD MILLION)
TABLE 197. ARGENTINA STEM CELL THERAPY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 198. ARGENTINA STEM CELL THERAPY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 199. EUROPE, MIDDLE EAST & AFRICA STEM CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 200. EUROPE, MIDDLE EAST & AFRICA STEM CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 201. EUROPE, MIDDLE EAST & AFRICA STEM CELL THERAPY MARKET SIZE, BY CELL SOURCE, 2018-2024 (USD MILLION)
TABLE 202. EUROPE, MIDDLE EAST & AFRICA STEM CELL THERAPY MARKET SIZE, BY CELL SOURCE, 2025-2030 (USD MILLION)
TABLE 203. EUROPE, MIDDLE EAST & AFRICA STEM CELL THERAPY MARKET SIZE, BY ADULT STEM CELLS, 2018-2024 (USD MILLION)
TABLE 204. EUROPE, MIDDLE EAST & AFRICA STEM CELL THERAPY MARKET SIZE, BY ADULT STEM CELLS, 2025-2030 (USD MILLION)
TABLE 205. EUROPE, MIDDLE EAST & AFRICA STEM CELL THERAPY MARKET SIZE, BY PERINATAL STEM CELLS, 2018-2024 (USD MILLION)
TABLE 206. EUROPE, MIDDLE EAST & AFRICA STEM CELL THERAPY MARKET SIZE, BY PERINATAL STEM CELLS, 2025-2030 (USD MILLION)
TABLE 207. EUROPE, MIDDLE EAST & AFRICA STEM CELL THERAPY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 208. EUROPE, MIDDLE EAST & AFRICA STEM CELL THERAPY MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 209. EUROPE, MIDDLE EAST & AFRICA STEM CELL THERAPY MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 210. EUROPE, MIDDLE EAST & AFRICA STEM CELL THERAPY MARKET SIZE, BY MODE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 211. EUROPE, MIDDLE EAST & AFRICA STEM CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 212. EUROPE, MIDDLE EAST & AFRICA STEM CELL THERAPY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 213. EUROPE, MIDDLE EAST & AFRICA STEM CELL THERAPY MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2024 (USD MILLION)
TABLE 214. EUROPE, MIDDLE EAST & AFRICA STEM CELL THERAPY MARKET SIZE, BY THERAPEUTIC AREAS, 2025-2030 (USD MILLION)
TABLE 215. EUROPE, MIDDLE EAST & AFRICA STEM CELL THERAPY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 216. EUROPE, MIDDLE EAST & AFRICA STEM CELL THERAPY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 217. EUROPE, MIDDLE EAST & AFRICA STEM CELL THERAPY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 218. EUROPE, MIDDLE EAST & AFRICA STEM CELL THERAPY MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 219. UNITED KINGDOM STEM CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 220. UNITED KINGDOM STEM CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 221. UNITED KINGDOM STEM CELL THERAPY MARKET SIZE, BY CELL SOURCE, 2018-2024 (USD MILLION)
TABLE 222. UNITED KINGDOM STEM CELL THERAPY MARKET SIZE, BY CELL SOURCE, 2025-2030 (USD MILLION)
TABLE 223. UNITED KINGDOM STEM CELL THERAPY MARKET SIZE, BY ADULT STEM CELLS, 2018-2024 (USD MILLION)
TABLE 224. UNITED KINGDOM STEM CELL THERAPY MARKET SIZE, BY ADULT STEM CELLS, 2025-2030 (USD MILLION)
TABLE 225. UNITED KINGDOM STEM CELL THERAPY MARKET SIZE, BY PERINATAL STEM CELLS, 2018-2024 (USD MILLION)
TABLE 226. UNITED KINGDOM STEM CELL THERAPY MARKET SIZE, BY PERINATAL STEM CELLS, 2025-2030 (USD MILLION)
TABLE 227. UNITED KINGDOM STEM CELL THERAPY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 228. UNITED KINGDOM STEM CELL THERAPY MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 229. UNITED KINGDOM STEM CELL THERAPY MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 230. UNITED KINGDOM STEM CELL THERAPY MARKET SIZE, BY MODE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 231. UNITED KINGDOM STEM CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 232. UNITED KINGDOM STEM CELL THERAPY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 233. UNITED KINGDOM STEM CELL THERAPY MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2024 (USD MILLION)
TABLE 234. UNITED KINGDOM STEM CELL THERAPY MARKET SIZE, BY THERAPEUTIC AREAS, 2025-2030 (USD MILLION)
TABLE 235. UNITED KINGDOM STEM CELL THERAPY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 236. UNITED KINGDOM STEM CELL THERAPY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 237. GERMANY STEM CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 238. GERMANY STEM CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 239. GERMANY STEM CELL THERAPY MARKET SIZE, BY CELL SOURCE, 2018-2024 (USD MILLION)
TABLE 240. GERMANY STEM CELL THERAPY MARKET SIZE, BY CELL SOURCE, 2025-2030 (USD MILLION)
TABLE 241. GERMANY STEM CELL THERAPY MARKET SIZE, BY ADULT STEM CELLS, 2018-2024 (USD MILLION)
TABLE 242. GERMANY STEM CELL THERAPY MARKET SIZE, BY ADULT STEM CELLS, 2025-2030 (USD MILLION)
TABLE 243. GERMANY STEM CELL THERAPY MARKET SIZE, BY PERINATAL STEM CELLS, 2018-2024 (USD MILLION)
TABLE 244. GERMANY STEM CELL THERAPY MARKET SIZE, BY PERINATAL STEM CELLS, 2025-2030 (USD MILLION)
TABLE 245. GERMANY STEM CELL THERAPY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 246. GERMANY STEM CELL THERAPY MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 247. GERMANY STEM CELL THERAPY MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 248. GERMANY STEM CELL THERAPY MARKET SIZE, BY MODE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 249. GERMANY STEM CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 250. GERMANY STEM CELL THERAPY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 251. GERMANY STEM CELL THERAPY MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2024 (USD MILLION)
TABLE 252. GERMANY STEM CELL THERAPY MARKET SIZE, BY THERAPEUTIC AREAS, 2025-2030 (USD MILLION)
TABLE 253. GERMANY STEM CELL THERAPY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 254. GERMANY STEM CELL THERAPY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 255. FRANCE STEM CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 256. FRANCE STEM CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 257. FRANCE STEM CELL THERAPY MARKET SIZE, BY CELL SOURCE, 2018-2024 (USD MILLION)
TABLE 258. FRANCE STEM CELL THERAPY MARKET SIZE, BY CELL SOURCE, 2025-2030 (USD MILLION)
TABLE 259. FRANCE STEM CELL THERAPY MARKET SIZE, BY ADULT STEM CELLS, 2018-2024 (USD MILLION)
TABLE 260. FRANCE STEM CELL THERAPY MARKET SIZE, BY ADULT STEM CELLS, 2025-2030 (USD MILLION)
TABLE 261. FRANCE STEM CELL THERAPY MARKET SIZE, BY PERINATAL STEM CELLS, 2018-2024 (USD MILLION)
TABLE 262. FRANCE STEM CELL THERAPY MARKET SIZE, BY PERINATAL STEM CELLS, 2025-2030 (USD MILLION)
TABLE 263. FRANCE STEM CELL THERAPY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 264. FRANCE STEM CELL THERAPY MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 265. FRANCE STEM CELL THERAPY MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 266. FRANCE STEM CELL THERAPY MARKET SIZE, BY MODE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 267. FRANCE STEM CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 268. FRANCE STEM CELL THERAPY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 269. FRANCE STEM CELL THERAPY MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2024 (USD MILLION)
TABLE 270. FRANCE STEM CELL THERAPY MARKET SIZE, BY THERAPEUTIC AREAS, 2025-2030 (USD MILLION)
TABLE 271. FRANCE STEM CELL THERAPY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 272. FRANCE STEM CELL THERAPY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 273. RUSSIA STEM CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 274. RUSSIA STEM CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 275. RUSSIA STEM CELL THERAPY MARKET SIZE, BY CELL SOURCE, 2018-2024 (USD MILLION)
TABLE 276. RUSSIA STEM CELL THERAPY MARKET SIZE, BY CELL SOURCE, 2025-2030 (USD MILLION)
TABLE 277. RUSSIA STEM CELL THERAPY MARKET SIZE, BY ADULT STEM CELLS, 2018-2024 (USD MILLION)
TABLE 278. RUSSIA STEM CELL THERAPY MARKET SIZE, BY ADULT STEM CELLS, 2025-2030 (USD MILLION)
TABLE 279. RUSSIA STEM CELL THERAPY MARKET SIZE, BY PERINATAL STEM CELLS, 2018-2024 (USD MILLION)
TABLE 280. RUSSIA STEM CELL THERAPY MARKET SIZE, BY PERINATAL STEM CELLS, 2025-2030 (USD MILLION)
TABLE 281. RUSSIA STEM CELL THERAPY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 282. RUSSIA STEM CELL THERAPY MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 283. RUSSIA STEM CELL THERAPY MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 284. RUSSIA STEM CELL THERAPY MARKET SIZE, BY MODE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 285. RUSSIA STEM CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 286. RUSSIA STEM CELL THERAPY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 287. RUSSIA STEM CELL THERAPY MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2024 (USD MILLION)
TABLE 288. RUSSIA STEM CELL THERAPY MARKET SIZE, BY THERAPEUTIC AREAS, 2025-2030 (USD MILLION)
TABLE 289. RUSSIA STEM CELL THERAPY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 290. RUSSIA STEM CELL THERAPY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 291. ITALY STEM CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 292. ITALY STEM CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 293. ITALY STEM CELL THERAPY MARKET SIZE, BY CELL SOURCE, 2018-2024 (USD MILLION)
TABLE 294. ITALY STEM CELL THERAPY MARKET SIZE, BY CELL SOURCE, 2025-2030 (USD MILLION)
TABLE 295. ITALY STEM CELL THERAPY MARKET SIZE, BY ADULT STEM CELLS, 2018-2024 (USD MILLION)
TABLE 296. ITALY STEM CELL THERAPY MARKET SIZE, BY ADULT STEM CELLS, 2025-2030 (USD MILLION)
TABLE 297. ITALY STEM CELL THERAPY MARKET SIZE, BY PERINATAL STEM CELLS, 2018-2024 (USD MILLION)
TABLE 298. ITALY STEM CELL THERAPY MARKET SIZE, BY PERINATAL STEM CELLS, 2025-2030 (USD MILLION)
TABLE 299. ITALY STEM CELL THERAPY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 300. ITALY STEM CELL THERAPY MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 301. ITALY STEM CELL THERAPY MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 302. ITALY STEM CELL THERAPY MARKET SIZE, BY MODE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 303. ITALY STEM CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 304. ITALY STEM CELL THERAPY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 305. ITALY STEM CELL THERAPY MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2024 (USD MILLION)
TABLE 306. ITALY STEM CELL THERAPY MARKET SIZE, BY THERAPEUTIC AREAS, 2025-2030 (USD MILLION)
TABLE 307. ITALY STEM CELL THERAPY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 308. ITALY STEM CELL THERAPY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 309. SPAIN STEM CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 310. SPAIN STEM CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 311. SPAIN STEM CELL THERAPY MARKET SIZE, BY CELL SOURCE, 2018-2024 (USD MILLION)
TABLE 312. SPAIN STEM CELL THERAPY MARKET SIZE, BY CELL SOURCE, 2025-2030 (USD MILLION)
TABLE 313. SPAIN STEM CELL THERAPY MARKET SIZE, BY ADULT STEM CELLS, 2018-2024 (USD MILLION)
TABLE 314. SPAIN STEM CELL THERAPY MARKET SIZE, BY ADULT STEM CELLS, 2025-2030 (USD MILLION)
TABLE 315. SPAIN STEM CELL THERAPY MARKET SIZE, BY PERINATAL STEM CELLS, 2018-2024 (USD MILLION)
TABLE 316. SPAIN STEM CELL THERAPY MARKET SIZE, BY PERINATAL STEM CELLS, 2025-2030 (USD MILLION)
TABLE 317. SPAIN STEM CELL THERAPY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 318. SPAIN STEM CELL THERAPY MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 319. SPAIN STEM CELL THERAPY MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 320. SPAIN STEM CELL THERAPY MARKET SIZE, BY MODE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 321. SPAIN STEM CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 322. SPAIN STEM CELL THERAPY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 323. SPAIN STEM CELL THERAPY MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2024 (USD MILLION)
TABLE 324. SPAIN STEM CELL THERAPY MARKET SIZE, BY THERAPEUTIC AREAS, 2025-2030 (USD MILLION)
TABLE 325. SPAIN STEM CELL THERAPY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 326. SPAIN STEM CELL THERAPY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 327. UNITED ARAB EMIRATES STEM CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 328. UNITED ARAB EMIRATES STEM CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 329. UNITED ARAB EMIRATES STEM CELL THERAPY MARKET SIZE, BY CELL SOURCE, 2018-2024 (USD MILLION)
TABLE 330. UNITED ARAB EMIRATES STEM CELL THERAPY MARKET SIZE, BY CELL SOURCE, 2025-2030 (USD MILLION)
TABLE 331. UNITED ARAB EMIRATES STEM CELL THERAPY MARKET SIZE, BY ADULT STEM CELLS, 2018-2024 (USD MILLION)
TABLE 332. UNITED ARAB EMIRATES STEM CELL THERAPY MARKET SIZE, BY ADULT STEM CELLS, 2025-2030 (USD MILLION)
TABLE 333. UNITED ARAB EMIRATES STEM CELL THERAPY MARKET SIZE, BY PERINATAL STEM CELLS, 2018-2024 (USD MILLION)
TABLE 334. UNITED ARAB EMIRATES STEM CELL THERAPY MARKET SIZE, BY PERINATAL STEM CELLS, 2025-2030 (USD MILLION)
TABLE 335. UNITED ARAB EMIRATES STEM CELL THERAPY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 336. UNITED ARAB EMIRATES STEM CELL THERAPY MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 337. UNITED ARAB EMIRATES STEM CELL THERAPY MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 338. UNITED ARAB EMI

Samples

Loading
LOADING...

Companies Mentioned

  • BrainStorm Cell Therapeutics Inc.
  • Merck KGaA
  • Anterogen Co., Ltd.
  • Astellas Pharma Inc.
  • Beike Biotechnology Co., Ltd.
  • Bristol-Myers Squibb Company
  • CellProthera SAS
  • Fate Therapeutics, Inc.
  • Gamida Cell Ltd.
  • Garuda Therapeutics
  • Holostem Terapie Avanzate S.r.l.
  • Jasper Therapeutics, Inc.
  • JCR Pharmaceuticals Co., Ltd.
  • Juvena Therapeutics Inc.
  • Kangstem Biotech Co., Ltd.
  • Kite Pharma, Inc. by Gilead Sciences, Inc.
  • Lonza Group AG
  • Medeze Group
  • Mesoblast Ltd.
  • Novo Nordisk A/S
  • Plasticell
  • ReNeuron Group PLC
  • SQZ Biotechnologies Company by Stemcell Technologies
  • Takara Bio Inc.
  • Thermo Fisher Scientific Inc.
  • U.S. Stem Cell Inc
  • Umoja Biopharma
  • Vericel Corporation

Table Information

Report AttributeDetails
No. of Pages183
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 5.08 Billion
Forecasted Market Value ( USD ) by 2030 $ 9.95 Billion
Compound Annual Growth Rate14.3%
Regions CoveredGlobal
No. of Companies Mentioned28

Related Topics

Related Reports

Stem Cell Therapy for Premature Ovarian Failure Market by Cell Type, Therapy Type, End User, Application - Global Forecast to 2030 - Product Image

Stem Cell Therapy for Premature Ovarian Failure Market by Cell Type, Therapy Type, End User, Application - Global Forecast to 2030

  • Report
  • 193 Pages
  • Global
From
Autologous Stem Cell & Non-Stem Cell Therapies Market by Therapy Type, Product Type, Indication, End User, Cell Source, Administration Route, Manipulation Level - Global Forecast 2025-2030 - Product Image

Autologous Stem Cell & Non-Stem Cell Therapies Market by Therapy Type, Product Type, Indication, End User, Cell Source, Administration Route, Manipulation Level - Global Forecast 2025-2030

  • Report
  • 189 Pages
  • Global
From
Stem Cell Therapy Market Size, Share & Trends Analysis Report By Therapy Type (Allogeneic Stem Cell Therapies, Autologous Stem Cell Therapies), By Therapeutic Application (Oncology), By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Stem Cell Therapy Market Size, Share & Trends Analysis Report By Therapy Type (Allogeneic Stem Cell Therapies, Autologous Stem Cell Therapies), By Therapeutic Application (Oncology), By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 100 Pages
  • Global
From
Mesenchymal Stem Cell Therapy Market Size, Share & Trends Analysis Report by Type (Autologous, Allogenic), Source (Bone Marrow, Umbilical Cord, Adipose), Disease Indication, Region, with Growth Forecasts, 2025-2030 - Product Image

Mesenchymal Stem Cell Therapy Market Size, Share & Trends Analysis Report by Type (Autologous, Allogenic), Source (Bone Marrow, Umbilical Cord, Adipose), Disease Indication, Region, with Growth Forecasts, 2025-2030

  • Report
  • 120 Pages
  • Global
From
Stem Cell Therapy Market Report and Forecast 2025-2034 - Product Image

Stem Cell Therapy Market Report and Forecast 2025-2034

  • Report
  • 400 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.